After ovarian cancer flop, PharmaMar’s lurbinectedin makes the cut lung cancer
26 Mar 2019 //
ENDPTS
PharmaMar & Chugai Agree to Terms for Early Termination License for Zepsyre®
26 Jun 2018 //
PR NEWSWIRE
26 Mar 2019 //
ENDPTS
26 Jun 2018 //
PR NEWSWIRE